Tag: U.K.
-
Florida Voters Give Split Decision on GM Mosquitoes [Updated]
Voters in the Florida Keys yesterday returned a split decision on non-binding ballot questions about testing genetically modified mosquitoes to stop the Zika virus.
-
Engineered Mosquito Production Facility Opens
A new industrial lab to produce mosquitoes genetically engineered to prevent the spread of infectious diseases opened in Piracicaba, Brazil.
-
Start-Up to Commercialize New Parkinson’s Treatment
Mavalon Therapeutics, a new company in the U.K., is being formed to bring a treatment to market that stops the progression of Parkinson’s disease.
-
St. Jude, Sanger Institute to Share Genomic Databases
Two research institutes — St. Jude Children’s Research Hospital and Wellcome Trust Sanger Institute — will share their databases on cancer genomics with the other institution’s scientists.
-
Challenge Seeks Health Technology Start-Ups
A new competition is seeking start-up enterprises worldwide to pitch their ideas for solving health care issues with technology directly to life sciences industry leaders.
-
Trial Testing Diabetes Drug as Parkinson’s Treatment
A clinical trial has started to test a current drug for type 2 diabetes as a treatment for Parkinson’s disease.
-
FDA Giving Fast-Track Review to Alzheimer’s Candidate
U.S. Food and Drug Administration is giving an accelerated review to a candidate drug designed to treat Alzheimer’s disease by reducing the toxicity of amyloid beta proteins making up the plaque accumulating in the brain.
-
New System Measures Oxygen Levels in ICU Patients
Researchers at University of Oxford in the U.K. designed a device that measures oxygen consumption in critically ill patients, to prevent occurrence of shock.
-
Stem Cells Banked for Bipolar Disorder Research
Stem cells from people with bipolar disorder are being collected by an academic-industry partnership for scientists worldwide who study the disorder.
-
GSK, Alphabet Form Bioelectronic Device Venture
Drug maker GlaxoSmithKline, or GSK, and Verily Life Sciences, a division of Alphabet, the parent company of Google, are forming a joint venture to develop miniaturized therapeutic electronic devices.